HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY

夏威夷健康公平临床研究网络

基本信息

  • 批准号:
    10709897
  • 负责人:
  • 金额:
    $ 149.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-24 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The overall goal of this application is to organize a local consortia of ambulatory primary care settings in Hawaii to form the Hawaii Clinical Research Network for Health Equity (HICRN-HE). The clinical research network will focus on the health disparity needs of the Indigenous Pacific People (IPP)–defined as Native Hawaiians, other Pacific Islanders, and Filipinos. The 2 largest health systems in Hawaii providing primary care to a substantial number of IPP [the Queen’s Health System (QHS) and Hawaii Pacific Health (HPH)] and Federally Qualified Health Centers on Oahu will be invited to join the HICRN-HE. The UG3 (first 2 years of the grant) phase will be devoted to developing the infrastructure for HICRN-HE. A secure analyzable and regularly updated patient data repository derived from electronic health records from QHS and HPH will be established to support database analyses of health disparity issues. A Clinical and Translational Research Registry will be created and maintained to link interested local researchers and their research capabilities with those seeking researchers for clinical research/trials. The HICRN-HE will develop a framework for monitoring the implementation phase of HICRN-HE clinical studies to ensure patient safety, adherence to study protocol, and ability to meet recruitment goals. The UH3 phase (years 3-5 of the grant) will be devoted to implementing 2 projects under the thematic health disparity problem of Non-Alcoholic Fatty Liver Disease (NAFLD). Project 1 will focus on NAFLD over the Lifespan in Hawaii and assess the prevalence, risk, co-morbidities, and age at onset of NAFLD in IPP. Project 2 will focus on rates and risks of NAFLD among our sexual and gender minority groups living with HIV to uncover the HIV-specific factors that may contribute to risk above and beyond those in the general population.
项目摘要/摘要 这个应用程序的总体目标是在夏威夷组织一个当地的流动初级保健机构联合体 成立夏威夷卫生公平临床研究网络(HICRN-HE)。临床研究网络将 重点关注土著太平洋人(IPP)的健康差距需求--定义为土著夏威夷人,其他 太平洋岛民和菲律宾人。夏威夷两个最大的卫生系统为大量的人提供初级保健 IPP[女王健康系统(QHS)和夏威夷太平洋健康(HPH)]的数量和联邦资格 瓦胡岛的卫生中心将被邀请加入HICRN-HE。UG3(赠款的头两年)阶段将是 致力于为HICRN-HE开发基础设施。一位安全、可分析并定期更新的患者 将建立来自QHS和HPH的电子健康记录的数据存储库,以支持 健康差距问题的数据库分析。将创建临床和翻译研究注册中心 并保持将感兴趣的当地研究人员及其研究能力与那些寻求 临床研究/试验的研究人员。HICRN-HE将制定一个框架,以监测 HICRN-HE临床研究的实施阶段,以确保患者安全,遵守研究方案,以及 有能力达到招聘目标。UH3阶段(赠款的第3-5年)将专门用于执行2 非酒精性脂肪性肝病(NAFLD)健康差距问题专题下的项目。项目1 将重点关注夏威夷的NAFLD,并评估患病率、风险、合并症和年龄 非酒精性脂肪肝在IPP中的发病。项目2将侧重于性和性别少数群体中NAFLD的发病率和风险 艾滋病毒携带者群体,以揭示可能导致风险的艾滋病毒特有因素 在普通人群中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Venkataraman Balaraman其他文献

Venkataraman Balaraman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Venkataraman Balaraman', 18)}}的其他基金

HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY
夏威夷健康公平临床研究网络
  • 批准号:
    10631836
  • 财政年份:
    2022
  • 资助金额:
    $ 149.35万
  • 项目类别:
Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials 2 (HIPACT 2)
夏威夷 IDeA 儿科和青少年临床试验中心 2 (HIPACT 2)
  • 批准号:
    10685355
  • 财政年份:
    2016
  • 资助金额:
    $ 149.35万
  • 项目类别:
Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials 2 (HIPACT 2)
夏威夷 IDeA 儿科和青少年临床试验中心 2 (HIPACT 2)
  • 批准号:
    10062215
  • 财政年份:
    2016
  • 资助金额:
    $ 149.35万
  • 项目类别:
Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials 2 (HIPACT 2)
夏威夷 IDeA 儿科和青少年临床试验中心 2 (HIPACT 2)
  • 批准号:
    10470907
  • 财政年份:
    2016
  • 资助金额:
    $ 149.35万
  • 项目类别:
Hawaii IDeA Center for Pediatric and Adolescent Clinical Trials 2 (HIPACT 2)
夏威夷 IDeA 儿科和青少年临床试验中心 2 (HIPACT 2)
  • 批准号:
    10241544
  • 财政年份:
    2016
  • 资助金额:
    $ 149.35万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 149.35万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了